—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
检验医学发现(英文)(LabMed Discovery)(OA期刊)(2024-2026年不收版面费)
CN外文 - 季刊
  • 检验医学发现(英文)(LabMed Discovery)(OA期刊)(2024-2026年不收版面费)
  • 复合影响因子:0
  • 国级普刊
  • 知网外文库,维普目次
  •  
  投稿方式:官网投稿
  • 栏目频次
  • 一作占比
  • 单位占比
  • 热词
暂无栏目信息.
暂无一作信息.
暂无单位信息.
暂无关键词信息.
  • 更多

    期刊简介

  • 《检验医学发现(英文)》(LabMed Discovery(LMD))(季刊),创刊于2023年,是上海交通大学主办,教育部主管,上海交通大学医学院医学技术学院官方刊物。LMD是一本高质量、同行评议(Peer-Review)、开放获取(Open-Access)的检验医学领域英文期刊。聚焦检验医学领域的前沿热点。内容涵盖检验医学基础科学、检验医学临床研究及检验医学转化应用等交叉学科、战略前沿和关键技术。

  • 基本信息

  • 期刊名称:检验医学发现(英文)(LabMed Discovery)(OA期刊)(2024-2026年不收版面费)
  • 主管单位:教育部
  • 主办单位:上海交通大学
  • 国内刊号:CN 31-2217/R4
  • 国际刊号:ISSN 2097-6852;eISSN 3050-4740
  • 出刊日期:
    期刊定价:
  • 邮发代码:
  • 所在省区:上海
    邮政编码:
  • 联系地址:

  • 投稿信息

  • 学科分类:临床医学
    版面费用:不收版面费
  • 字数要求:-
    查重要求:- ;AIGC检测:-
  • 复合因子:0
    综合因子:0
  • 审  稿 费:
    稿费:待核实
  • 审稿类型:默认
    是否加急:
  • 本刊可发:
  • 特殊属性:外文期刊

  • 联系方式

  • 投稿网址:https://www.editorialmanager.com/lmd/Default.aspx
  • 官网网址:https://www.sciencedirect.com/journal/labmed-discovery/
  • 电话传真:021-64370045-611425(官网);64374749(微信公众号信息)
  • 电子邮箱:labmed@rjh.com.cn(官网邮箱)
  • 微信公众号:瑞金检验医学(MedResearchInno)

审稿时间:暂无参考数据,审稿时间不确定!

投稿难度:网友分享,仅供参考

见刊周期:-

温馨提示以上只是参考信息,实际情况会根据投稿主题、稿件质量和数量、审稿流程有所差异。想获得更准确信息请联系期刊的编辑部进行咨询。

欢迎点评!让信息更透明,使投稿更轻松!
    • 审稿时间:
      是否录用:
    • 发表排期:
      查重要求:
    • 有无课题:
      有无回复:
    • 我的学历:
      我的职称:
    • 审稿费用:
      版面费用:
    • 稿       费:
      稿件字数:
    • 投稿难度:
    • 该刊可发:
    • 投稿主题:
匿名: 验证码: 点击切换验证码
    • 1、投稿方式:在线投稿。

      2、官网网址:

      https://www.sciencedirect.com/journal/labmed-discovery/

      https://mrijournal.rjh.com.cn:8443/

      (上海交通大学期刊中心进入)

      3、投稿系统:

      https://www.editorialmanager.com/lmd/Default.aspx

      4、官网邮箱:labmed@rjh.com.cn

      5、联系电话:

      021-64370045-611425(官网信息)

      021-64374749(微信公众号信息)

      6、出刊日期:季刊,逢季末月出版。

      7、公众号信息:2024-2026年免收文章处理费(APC)。

      8、官网微信公众号:瑞金检验医学(MedResearchInno)

      2025年8月8日星期五

      关于期刊LabMed Discovery (《检验医学发现(英文)》

      【官方微信公众号信息】

      瑞金检验医学2025年08月07日

      LabMed Discovery (《检验医学发现(英文)》,LMD,CN 31-2217/R4,ISSN 3050-4740)是一本高质量、同行评议、开放获取(钻石OA)的检验医学领域英文期刊,已被美国化学文摘(CAS)、美国乌利希国际期刊指南(Ulrich)、波兰哥白尼索引数据库(ICI World of Journals)、EBSCO、Science Direct、Scilit、Google Scholar、OpenAlex、Crossref、EZB、COAJ、CNKI等数据库收录,为上海交通大学医工交叉期刊联盟成员单位、血液学期刊联盟理事单位。以“引领检验医学技术创新,推动医学技术国际交流”为使命,以创办世界一流检验医学交叉领域学术期刊,填补国内检验医学英文期刊的学术空白为目标,旨在全方位、多角度展示检验医学与内分泌代谢、肿瘤学、影像学、核医学、微生物学、病理学等学科的交叉与融合,以此搭建医学技术与临床医学之间的桥梁,服务科研工作者、临床医师和精准医学、智能医学、检验专业的相关学者,促进检验医学的多学科交叉融合发展。聚焦检验医学领域的前沿热点、关键技术及创新成果,分享检验医学领域的最新研究进展、传播新观点、交流新技术、分享新成果。内容涵盖检验医学基础科学、检验医学临床研究及医学最新成果的转化应用。2023年入选“中国科技期刊卓越行动计划高起点新刊”项目。

      网站:https://www.sciencedirect.com/journal/labmed-discovery

      投稿:https://www.editorialmanager.com/lmd/default2.aspx

      邮箱:labmed@rjh.com.cn

      电话:021-64374749

      Guide for authors

      【官网信息】

      ......

      Peer review (single blind)

      This

      journal operates a single-blind review process. All contributions will

      be initially assessed by the Editor for suitability for the journal.

      Papers deemed suitable are then typically sent to a minimum of two

      independent expert reviewers to assess the scientific quality of the

      paper. The Editor is responsible for the final decision regarding

      acceptance or rejection of articles. The Editor’s decision is final.

      Editors are not involved in decisions about papers that they have

      written themselves or that have been written by their family members or

      colleagues or that relate to products or services in which the Editor

      has an interest. Any such submission is subject to all of the journal’s

      usual procedures, with peer review handled independently of the relevant

      Editor and their research groups. More information on types of peer

      review.

      All

      manuscripts will be first reviewed by the assigned Editors. Any papers

      failing to meet the basic standard of the journal will be desk rejected

      for such reasons as out of scope, ethical conflicts, high similarities,

      lack of originality, and flaws in research design or methods.

      After

      at least 2 reviewers give their reviews and comments, the assigned

      Editor will provide feedback based on review comments to the authors,

      including their own review comments.

      When

      author submits the revised manuscript, the assigned Editor will

      collaborate to make the final decision with Editorial Board.

      For

      submissions from Editor-in-Chief, Associate Editors, Guest Editor(s),

      other journal Board members, and authors who have conflicts of interest

      with them, we ensure that the paper is handled confidentially by a

      different team member.

      For

      submissions to Special Issues, if there are conflicts of interest

      between the Guest Editor(s) and authors, the submissions will be handled

      by another Editor from the Editorial Board, who will manage the peer

      review process and make the decision whether to accept or reject the

      paper after peer review.

      Open access

      Please visit our Open Access page for more information.

      Submission checklist

      You

      can use this list to carry out a final check of your submission before

      you send it to the journal for review. Please check the relevant section

      in this Guide for Authors for more details.

      Ensure that the following items are present:

      One author has been designated as the corresponding author with contact details:

      E-mail address

      Full postal address

      All necessary files have been uploaded:

      Manuscript

      Include keywords

      All figures (include relevant captions)

      All tables (including titles, description, footnotes)

      Ensure

      all figure and table citations in the text match the files provided;

      Indicate clearly if color should be used for any figures in print

      Graphical Abstracts / Highlights files (where applicable)

      Supplemental files (where applicable)

      Further considerations:

      Manuscript has been 'spell checked' and 'grammar checked'

      All references mentioned in the Reference List are cited in the text, and vice versa

      Permission has been obtained for use of copyrighted material from other sources (including the Internet)

      A competing interests statement is provided, even if the authors have no competing interests to declare

      Journal policies detailed in this guide have been reviewed

      For further information, visit our Support Center.

      Before you begin

      Ethics in publishing

      Please see our information on Ethics in publishing.

      Declaration of competing interest

      Corresponding

      authors, on behalf of all the authors of a submission, must disclose

      any financial and personal relationships with other people or

      organizations that could inappropriately influence (bias) their work.

      Examples of potential conflicts of interest include employment,

      consultancies, stock ownership, honoraria, paid expert testimony, patent

      applications/registrations, and grants or other funding. All authors,

      including those without competing interests to declare, should provide

      the relevant information to the corresponding author (which, where

      relevant, may specify they have nothing to declare). Corresponding

      authors should then use this tool to create a shared statement and

      upload to the submission system at the Attach Files step. Please do not

      convert the .docx template to another file type. Author signatures are

      not required.

      Declaration of generative AI in scientific writing

      The

      below guidance only refers to the writing process, and not to the use

      of AI tools to analyse and draw insights from data as part of the

      research process.

      Where

      authors use generative artificial intelligence (AI) and AI-assisted

      technologies in the writing process, authors should only use these

      technologies to improve readability and language. Applying the

      technology should be done with human oversight and control, and authors

      should carefully review and edit the result, as AI can generate

      authoritative-sounding output that can be incorrect, incomplete or

      biased. AI and AI-assisted technologies should not be listed as an

      author or co-author, or be cited as an author. Authorship implies

      responsibilities and tasks that can only be attributed to and performed

      by humans, as outlined in Elsevier's AI policy for authors.

      Authors

      should disclose in their manuscript the use of AI and AI-assisted

      technologies in the writing process by following the instructions below.

      A statement will appear in the published work. Please note that authors

      are ultimately responsible and accountable for the contents of the

      work.

      Disclosure instructions

      Authors

      must disclose the use of generative AI and AI-assisted technologies in

      the writing process by adding a statement at the end of their manuscript

      in the core manuscript file, before the References list. The statement

      should be placed in a new section entitled 'Declaration of Generative AI

      and AI-assisted technologies in the writing process'

      Statement:

      During the preparation of this work the author(s) used [NAME TOOL /

      SERVICE] in order to [REASON]. After using this tool/service, the

      author(s) reviewed and edited the content as needed and take(s) full

      responsibility for the content of the publication

      This

      declaration does not apply to the use of basic tools for checking

      grammar, spelling, references etc. If there is nothing to disclose,

      there is no need to add a statement.

      Submission declaration and verification

      Submission

      of an article implies that the work described has not been published

      previously (except in the form of an abstract, a published lecture or

      academic thesis, see 'Multiple, redundant or concurrent publication' for

      more information), that it is not under consideration for publication

      elsewhere, that its publication is approved by all authors and tacitly

      or explicitly by the responsible authorities where the work was carried

      out, and that, if accepted, it will not be published elsewhere in the

      same form, in English or in any other language, including electronically

      without the written consent of the copyright-holder. To verify

      compliance, your article may be checked by Crossref Similarity Check and

      other originality or duplicate checking software.

      Preprints

      Please

      note that preprints can be shared anywhere at any time, in line with

      Elsevier's sharing policy. Sharing your preprints e.g. on a preprint

      server will not count as prior publication (see 'Multiple, redundant or

      concurrent publication' for more information).

      ......

      更多详见:

      https://www.sciencedirect.com/journal/labmed-discovery/publish/guide-for-authors


    评分:0

    验证码: 点击切换验证码